SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Latigo Biotherapeutics Announces CEO Transition

Todd N. Smith, described as an executive with experience commercializing pain therapies, was appointed CEO.

LTGO

Related stories